Skip to main content
Equibles

CURA · Curaleaf Holdings, Inc. · Investor Relations

Use CURA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CURA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
11.7700 CAD -0.3600 (-2.97%) At close · Oct 30 Intraday price with Plus Earnings today
Rebalance outlook locked

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-03 22:00 UTC Q3 FY2026 Earnings conference call (announced in 8-K) Earnings call

Recent news

Date Headline
2026-10-28 Curaleaf Responds to Alberta Securities Commission Decision
2026-10-19 Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal
2026-10-06 Curaleaf Files Update to Offering Circular Curaleaf has filed a formal update to its Circular incorporating its previously announced increased Offer for Aurora Curaleaf continues to call on Aurora to engage regarding its Offer and provide shareholders with a comprehensive view of the potential of the combined businesses STAMFORD, Conn.
2026-10-06 Curaleaf Enhances Offer to Acquire Aurora Cannabis
2026-10-01 Curaleaf to Report Third Quarter 2026 Financial and Operational Results
2026-10-01 SOURCE Curaleaf Holdings, Inc. https://ir.curaleaf.com/2026-09-23-Curaleaf-Added-to-FTSE-Canada-All-Cap-Index
2026-09-15 Curaleaf Sends Letter to Aurora Shareholders Encourages Them to Tender Their Shares and Become Owners of the World's Leading Cannabis Company Announces Live Shareholder Q&A with Curaleaf Chairman and CEO Boris Jordan on Thursday, September 17 at 10:30 a.m. ET Read the Full Shareholder Letter and Register for Q&A at Grow.Curaleaf.com STAMFORD, Conn.
2026-09-14 Curaleaf Submits Application to Alberta Securities Commission to Halt Aurora's ATM Program During Pending Offer Argues Aurora's share issuances are an improper and abusive defensive tactic that dilutes shareholders and interferes with consideration of Curaleaf's premium offer Aurora's ATM issuances have diluted Aurora shareholders by ~11% since implementation of the ATM program and by approximately ~5% since June 2026, and increased the cost of Curaleaf's offer by more than US$11 million STAMFORD, Conn.
2026-09-08 Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora
2026-09-02 Curaleaf Responds to Aurora Circular; Reaffirms Offer as the Best Path to Value Creation for Shareholders Highlights Curaleaf Offers a 45% Premium and Meaningful Future Upside: Aurora shareholders can realize immediate value alongside the opportunity to participate in the upside of a substantially larger, more diversified cannabis platform. Aurora Promotes a "Debt-Free" Balance Sheet While Overlooking Years of Shareholder Dilution to Fund It: Since September 2020, Aurora has raised $398 million in capital a
2026-08-25 Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation Aurora's selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value Curaleaf reiterates its willingness to meet anytime to discuss a deal in the best interests of shareholders STAMFORD, Conn.
2026-08-18 Curaleaf Launches Take-Over Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender to the Bid Formal offer and take-over bid circular filed and will be delivered to Aurora shareholders Offer provides total implied consideration of US$4.00 per share, representing a 45% premium to Aurora’s Unaffected Share Price and a premium of 110% on an ex-cash basis to Aurora’s Unaffected Share Price Curaleaf remains prepared to engage constructively with Aurora’s Board regarding this value-maximizing trans
2026-08-12 Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash Provides Aurora shareholders with the opportunity to become owners of the premier global cannabis platform and participate in the significant long-term upside of the combined company Combines Aurora's EU-GMP cultivation and manufacturing cap
2026-08-06 Curaleaf Reports Second Quarter 2026 Results: Continued Growth, Margin Strength, and Profitability

Past events

Date Event Type
2026-08-05 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-05-05 CURALEAF HOLDINGS, INC. – FIRST QUARTER 2026 CONFERENCE CALL Earnings call
2026-02-26 CURALEAF HOLDINGS, INC. – FOURTH QUARTER AND FULL YEAR 2025 CONFERENCE CALL Earnings call
2025-11-05 CURALEAF HOLDINGS, INC. – THIRD QUARTER 2025 CONFERENCE CALL Earnings call
2025-08-06 CURALEAF HOLDINGS, INC. – SECOND QUARTER 2025 CONFERENCE CALL Earnings call
2025-05-08 CURALEAF HOLDINGS, INC. – FIRST QUARTER 2025 CONFERENCE CALL Earnings call
2025-03-03 CURALEAF HOLDINGS, INC. – FOURTH QUARTER AND FISCAL YEAR END 2024 EARNINGS CONFERENCE CALL Earnings call
2024-11-06 CURALEAF HOLDINGS, INC. – THIRD QUARTER 2024 CONFERENCE CALL Earnings call
2024-08-07 CURALEAF HOLDINGS, INC. – SECOND QUARTER 2024 EARNINGS CONFERENCE CALL Earnings call
2024-06-25 CANNABIS EUROPA Event
2024-05-09 CURALEAF HOLDINGS, INC. – FIRST QUARTER 2024 EARNINGS CONFERENCE CALL Earnings call

Source: https://ir.curaleaf.com/